NCT01217307 Metformin to Reduce Heart Failure After Myocardial Infarction Status COMPLETED Phase PHASE2/PHASE3
NCT01217073 A Dose-Range Finding Study in Participants With Type 2 Diabetes (MK-3102-006) Status COMPLETED Phase PHASE2
NCT01208740 Metformin in Patients With PCOS and Predictors of Poor Ovarian Response Ongoing In-vitro Fertilization Status TERMINATED Phase PHASE4
NCT01206153 Metformin for Treatment Antipsychotic Induced Amenorrhea in Female Schizophrenic Patients Status COMPLETED Phase PHASE4
NCT01205672 Evaluation of the Molecular Effects of Metformin on the Endometrium in Patients With Endometrial Cancer Status COMPLETED Phase EARLY_PHASE1
NCT01187849 Metformin to Prevent Metabolic Complications in Glucocorticoid Excess Status COMPLETED Phase PHASE4
NCT01181674 Remission Evaluation of Metabolic Interventions in Type 2 Diabetes (REMIT Pilot Trial) Status COMPLETED Phase PHASE4
NCT01175473 Effects of Lixisenatide Compared to Liraglutide on the Postprandial Plasma Glucose in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT01169779 Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled by Metformin Status COMPLETED Phase PHASE3
NCT01167738 Combination Chemotherapy With or Without Metformin Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer Status TERMINATED Phase PHASE2
NCT01160068 Bioequivalence Study of Metformin Hydrochloride Tablets 1000 mg Tablets of Dr. Reddy's Laboratories Limited Under Fed Condition Status COMPLETED Phase PHASE1
NCT01160042 Bioequivalence Study of Metformin Hydrochloride Tablets 1000 mg Tablets of Dr. Reddy's Laboratories Limited Under Fasting Condition Status COMPLETED Phase PHASE1
NCT01137812 The CANTATA-D2 Trial (CANagliflozin Treatment And Trial Analysis - DPP-4 Inhibitor Second Comparator Trial) Status COMPLETED Phase PHASE3
NCT01135433 A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Type 2 Diabetic Patients Status COMPLETED Phase PHASE3
NCT01131182 Study of Sitagliptin Treatment in Patients With Type 2 Diabetes During Ramadan (0431-263) Status COMPLETED Phase PHASE4